- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03614780
Pre Post Evaluation of Temperature, Steps, and Glucose With Additional Time Spent Outdoors in an Urban and Rural Setting
August 2, 2018 updated by: Julia Gohlke, Virginia Polytechnic Institute and State University
Environmental Exposures Across Urban and Rural Communities in the Deep South
This research was designed with partners to determine differences in temperature exposures in urban and rural communities in Alabama.
The investigators hypothesized that significant differences in temperature exposure exist between urban and rural settings.
Time spent outdoors has been previously positively associated with greater physical activity.
Built environment components in urban versus rural environments and ambient temperatures experienced during the summer may pose barriers to time spent outdoors.
Persons with Type II Diabetes Mellitus may find it more difficult to overcome temperature barriers due to reduced thermoregulation capacity.
This analysis will result in a more precise picture of temperature exposure as well as behavioral factors that may mediate exposure.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The investigators gathered individual-level temperature exposure data by asking 180 female participants to wear a small thermometer on their shoe for 7 days.
Ninety participants were recruited from Birmingham AL (urban) and 90 from rural West Central Alabama.
The first two days participants were asked to go about their normal daily activities.
During the next 5 days of participation, participants were asked to add an additional 30 minutes of time spent outdoors.
As a secondary outcome, steps were measured via pedometers worn by participants.
A subgroup of participants with self-reported doctor diagnosed Type II Diabetes also recorded their fasting glucose each morning of participation.
Study Type
Interventional
Enrollment (Actual)
180
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35294
- Center for the Study of Community Health
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Female, age 19 to 65, willing to wear a small thermometer on shoe and pedometer on waist for one week.
Exclusion Criteria:
- Medical condition that limits the amount of time able to be spent outdoors.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 30 additional minutes outdoors
Participants were asked to go about their normal activities during the first 2 baseline days of participation.
Participants were asked to spend an additional 30 minutes outdoors per day for the next 5 days of participation.
|
Participants were asked to add an additional 30 minutes of time spent outdoors during the last 5 days of participation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
temperature
Time Frame: 7 days
|
participants wore a small thermometer on their shoe that recorded temperature in 5 minute intervals for the duration of participation
|
7 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
steps
Time Frame: 7 days
|
participants wore a pedometer and recorded steps daily
|
7 days
|
fasting glucose
Time Frame: 7 days
|
Participants (N=46) that self reported diagnosed T2DM and measured daily fasting glucose were asked to log their fasting glucose level each morning.
|
7 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Julia M Gohlke, PhD, Virginia Polytechnic Institution and State University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 11, 2017
Primary Completion (Actual)
July 19, 2017
Study Completion (Actual)
July 19, 2017
Study Registration Dates
First Submitted
July 27, 2018
First Submitted That Met QC Criteria
July 27, 2018
First Posted (Actual)
August 3, 2018
Study Record Updates
Last Update Posted (Actual)
August 6, 2018
Last Update Submitted That Met QC Criteria
August 2, 2018
Last Verified
August 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 15-761
- R01ES023029 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus, Type 2
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Mannkind CorporationTerminatedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
Griffin HospitalCalifornia Walnut CommissionCompletedDIABETES MELLITUS TYPE 2United States
-
RWTH Aachen UniversityBoehringer IngelheimCompletedDiabetes Mellitus Type 2 (T2DM)Germany
-
University Hospital Inselspital, BerneCompletedType 2 Diabetes MellitusSwitzerland
-
India Diabetes Research Foundation & Dr. A. Ramachandran...CompletedTYpe 2 Diabetes MellitusIndia
-
AstraZenecaRecruiting
-
Daewoong Pharmaceutical Co. LTD.Not yet recruitingT2DM (Type 2 Diabetes Mellitus)
-
Zhongda HospitalRecruitingType 2 Diabetes Mellitus (T2DM)China
-
Newsoara Biopharma Co., Ltd.RecruitingT2DM (Type 2 Diabetes Mellitus)China
Clinical Trials on 30 minutes outdoors
-
University of Sao PauloActive, not recruiting
-
Instituto Nacional de RehabilitacionNational Council of Science and Technology, MexicoCompleted
-
Charite University, Berlin, GermanyRecruitingPlacenta; RetentionGermany
-
University of Illinois at Urbana-ChampaignCompletedBreast Cancer | Physical Activity | Cognitive Impairment | Cancer-related Problem/Condition
-
Medical University of South CarolinaCompleted
-
Hillerod Hospital, DenmarkUnknownPhysical Activity | Acute Ischemic Stroke | AccelerometerDenmark
-
Hillerod Hospital, DenmarkUnknown
-
Dartmouth-Hitchcock Medical CenterCompleted
-
Maastricht University Medical CenterCompletedBlood Loss | Hepatocellular InjuryNetherlands
-
Karolinska InstitutetCompletedThrombosis | Vascular Function | Microcirculation | Heated Tobacco Products | Blood Markers | Microvesicles | NETsSweden